Role of apoptosis in HIV disease pathogenesis

Journal of Clinical Immunology

Volumn 15, Issue 5, 1995, Pages 217-231

  Oyaizu, Naoki ^a   Pahwa, Savita ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

apoptosis; Bel 2; cytokine; cytopathicity; Fas; HIV 1; pathogenesis

Indexed keywords

CD4 ANTIGEN; FAS ANTIGEN; GLYCOPROTEIN GP120; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; CYTOPATHOGENIC EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMAL; APOPTOSIS; HIV INFECTIONS; HUMAN; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0028785967     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/BF01540879     Document Type: Article

References (165)

1. Viral dynamics in human immunodeficiency virus type 1 infection
2. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
3. HIV-1-induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo
4. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes
5. Induction of CD4-dependent cell fusion by the HTLVIII/LAV envelope protein
6. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity
7. A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion
8. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope protein
9. Dissociation of unintegrated viral DNA accumulation from single-cell lysis induced by human immunodeficiency virus type 1
10. Pertubation of host-cell membrane is a primary mechanism of HIV cytopathicity
11. Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS
12. The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing
13. Differential response to the cytopathic effects of human T-cell lymphotropic virus III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-1
14. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1
15. The cytopathic effect of HIV is associated with apoptosis
16. Membrane expression of HIV envelope glycoprotein triggers apoptosis in CD4 cells
17. Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1
18. Defective expression of hematopoietic cell protein phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis
19. The immunopathogenesis of human immunodeficiency virus infection
20. Pathogenesis of human immunodeficiency virus infection
21. T-cell-mediated immunopathology versus direct cytolysis: implication for HIV and AIDS
22. Apoptosis: a basic biological phenomenon with wide ranging implication in tissue kinetics
23. Cell death: the significance of apoptosis
24. Activation-driven T cell death. I: Requirements for de novo transcription and translation and association of genome fragmentation
25. Cell growth cycle block of T cell hybridomas upon activation with antigen
26. Requirement for orphan steroid receptor Nur77 in apoptosis of T-cell hybridoma
27. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur 77
28. Role for c-myc in activation-induced cell death in T cell hybridoma
29. The Fas death factor
30. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor
31. Monoclonal antibody-mediated tumor regression by induction of apoptosis
32. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
33. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
34. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease
35. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
36. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
37. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
38. The mouse Fas-ligand gene is mutated in gld mice and is part of TNF family gene cluster
39. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
40. Fas ligand mediates activation-induced cell death in human T lymphocytes
41. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
42. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridoma
43. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation
44. Selection of the T cell receptor repertoire in lpr mice
45. The expansion of a CD4+ T cell population bearing a distinctive β chain in MRL lpr/lpr mice suggests a role of the Fas protein in peripheral T cell selection
46. The Fas antigen is involved in peripheral but not thymic detection of T lymphocytes in T cell receptor transgenic mice
47. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide
48. Mature CD4+ T lymphocytes from MRL/lpr ice are resistant to receptor-mediated tolerance and apoptosis
49. Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells
50. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells
51. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
52. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes
53. Effect of bcl-2 on Fas antigenmediated cell death
54. Target disruption of Bcl-2αβ in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia
55. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulation in human peripheral blood
56. Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes
57. Expression of Bcl-2 protein in murine and human thymocytes and peripheral T lymphocytes
58. The progressive differentiation of primed T cells is associated with an increased susceptibility to apoptosis
59. Bcl-2 expression during T-cell development: early loss and late return occur at specific stages of commitment to differentiation and survival
60. Apoptotic cell death of primed CD45R0+ T lymphocytes in Epstein-Barr virus-induced infections mononucleosis
61. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
62. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL
63. Programmed cell death and Bcl-2 protection in very low oxigen
64. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
65. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax
66. bcl-x, bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
67. Bad, a heterodimetric partner for Bcl-xL and Bcl-2, displaces Bax and promote cell death
68. Induction of apoptosis by the Bcl-2 homologue Bak
69. Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity
70. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement
71. Fas transduce activation signals in normal human T lymphocytes
72. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen
73. FAP-1: A protein tyrosine phosphatase that associate with Fas
74. Programmed cell death induced by ceramide
75. Functional dichotomy of neutral and acid sphingomyelinases in tumor necrosis factor signaling
76. Change in bioactive lipids, alkyacylglycerol and ceramide, occur in HIV-infected cells
77. Involvement of the sphingomyelin pathway in autocrine tumor necrosis factor signaling for human immunodeficiency virus production in chronically infected HL-60 cells
78. Protease inhibitors selectively block T-cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T-cells
79. Altered cytokine export and apoptosis in mice deficient in interleukin-1 β converting enzyme
80. Involvement of an ICE-like protease in Fas-mediated apoptosis
81. Requirement of an ICE/CED-3 protease for Fas/Apo-1-mediated apoptosis
82. Programmed death of T cells in HIV-1 infection
83. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency-infected asymptomatic individuals
84. Accelerated apoptosis in peripheral blood mononuclear cells (PBMC) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals
85. Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric method
86. Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors
87. Programmed death of T cells in human immunodeficiency virus infection
88. Anergy and apoptosis in CD8+ T cells from HIV-infected persons
89. Analysis of lymphocyte cell death and apoptosis in HIV-2-infected patients
90. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4
91. Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes
92. HIV induces thymus depletion in vivo
93. The combined assessment of cellular apoptosi, mitochondrial function and proliferative response to pokeweed mitogen fas prognostic value in SIV infection
94. PCD (apoptosis) as a mechanism of cell death in PBMC from cats infected with feline immunodeficiency virus (FIV)
95. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations
96. Inhibition of CD4+ T-cell function by the HIV envelope protein gp120
97. Inhibition of functional properties of tetyanus antigen-specific T cell clones by envelope glycoproteins of HIV-1
98. Human immunodeficiency virus type 1 envelope protein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA
99. Role of CD4 molecule in the induction of interleukin 2 and interleukin 2 receptor in class II major histocompatibility complex-restricted antigen specific T helper clones
100. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen
101. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis
102. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients
103. CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients
104. Autoantibodies against CD4 cells are associated with CD4 helper defects in human immunodeficiency virus-infected patients
105. Crosslinking of CD4 Molecules Up-regulates Fas Antigen Expression in Lymphocytes by Inducing Interferon τ and Tumor Necrosis Factor- α Secretion
106. Differential lymphokine profile of functional subsets of human CD4 and CD8 T cell clone
107. Generation and in vivo persistence of polarized Th1 and Th2 memory cells
108. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation
109. The significance of low bcl-2 expression by CD45R0 T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory
110. A Th1-Th2 switch is a critical step in the etiology of HIV infection
111. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals
112. Elevated levels of circulating cahectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
113. Infection with HIV is associated with elevated IL-6 levels and production
114. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes
115. Elevated INF- τ and decreased IL-2 gene expression are associated with HIV infection
116. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals
117. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1
118. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion
119. Human immunodeficiency virus type 1 envelope glycoprotein gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clones
120. Recombinant gp120 specifically enhances tumor necrosis factor- α production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors
121. Effect of HIV-1 envelope protein gp160 on cytokine production from cord blood T cells
122. Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocyte macrophage
123. CD4 engagement induces Fas antigen-dependent apoptosis in vivo
124. High expression of Apo-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children
125. Expression of the Fas antigen in patients infected with human immunodeficiency virus
126. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication
127. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: Role in AIDS pathogenesis
128. Sequence homology between HIV-1 gp120 and the apoptosis mediating protein Fas
129. Fas and tumor necrosis factor receptor-mediated cell death: Similarities and distinctions
130. TCR cross-linking induces CTL death via internal action of TNF
131. Interferon τ plays a critical role in induced cell death of effector T cell: A possible third mechanism of self-tolerance
132. CD3-mediated apoptosis of human medullary thymocytes and activated T cells: respective roles of interleukin-1, interleukin-2, interferon- τ and accessory cells
133. Environmental signals influence expression of the IFN- τ receptor on human T cells control whether IFN- τ promotes proliferation or apoptosis
134. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis
135. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis
136. Conjugate of dendritic cells and memory T lymphocytes from skin facilitate productive infection of HIV-1
137. CTLA4 mediates antigen-specific apoptosis of human T-cells
138. Expression of Fas ligand in cells of T cell lineage
139. Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients
140. Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates
141. A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease
142. Long-term observations of human immunodeficiency virus-infected chimpanzees
143. The inability of human immunodeficiency virus to infect chimpanzee monocytes can be overcome by serial passage in vivo
144. Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants
145. A virus-encoded “superantigen” in a retrovirus-induced immunodeficiency syndrome of mice
146. Sever immunodeficiency disease induced by a defective murine leukemia virus
147. Complement-mediated follicular localization of T-independent type-2 antigens: the role of marginal zone macrophage
148. How B and T cells talk to each other
149. Early stages of simian immunodeficiency virus infection in lymph nodes
150. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
151. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
152. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes
153. Germinal center T cells are distinct helper-inducer T cells
154. T cells within germinal centers are specific for the immunizing antigen
155. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
156. Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent
157. Tumor necrosis factor-alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kB sites in the long terminal repeat
158. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor α by transcriptional and post-transcriptional mechanisms
159. Interferon-gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells
160. Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: Do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells?